Propranolol on Post Stroke Immune Status and Infection

Clinical trial NCT05375240 · UNKNOWN

Trial details

NCT number: NCT05375240
Sponsor: Tianjin Medical University General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke Cerebrovascular Disorders Ischemic Stroke Brain Diseases Central Nervous System Diseases Nervous System Diseases Cardiovascular Diseases Propranolol Beta Blocker Molecular Mechanisms of Pharmacological Action Immunologic Factors Physiological Effects of Drugs

Start date: 2022-06-01
Primary completion: 2024-06-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.